Director dealings: Benchmark CEO ups stake
Benchmark Holdings
36.95p
08:04 15/11/24
Benchmark Holdings said on Friday that chief executive Trond Williksen had acquired 180,000 ordinary shares in the AIM-listed veterinary services company.
FTSE AIM 100
3,528.04
15:45 15/11/24
FTSE AIM All-Share
728.67
15:45 15/11/24
Pharmaceuticals & Biotechnology
19,259.77
15:45 15/11/24
Williksen, who took over as CEO back in June, purchased the shares earlier in the week at an average price of 46.00p each, for a total value of £82,800.
Just last week, Benchmark said that pre-tax losses had widened so far in 2020 as revenues slipped amid the Covid-19 pandemic.
Benchmark said year-to-date revenues were £81.6m, down from the £90.1m recorded in the first nine months of the prior year, while pre-tax losses from continuing operations widened to £27.4m from £18.2m.
As of 1630 BST, Benchmark shares were flat at 45.0p.
Top Director Buys
Benchmark Holdings (BMK)
Director name: Williksen,Trond
Amount purchased: 180,000 @ 46.00p
Value: £82,800.00
Paragon Banking Group (PAG)
Director name: Terrington,Nigel S
Amount purchased: 7,987 @ 348.98p
Value: £27,873.03
Sureserve Group (SUR)
Director name: Holt,Bob
Amount purchased: 44,422 @ 51.00p
Value: £22,655.22
Fuller Smith & Turner (FSTA)
Director name: Rowland,Robin
Amount purchased: 3,551 @ 560.00p
Value: £19,885.60
Paragon Banking Group (PAG)
Director name: Woodman,Richard
Amount purchased: 5,134 @ 348.98p
Value: £17,916.63
Jupiter Fund Management (JUP)
Director name: Sternberg,Karl
Amount purchased: 7,500 @ 210.40p
Value: £15,780.00
Top Director Sells
Henderson Alternative Strategies Trust (HAST)
Director name: Oldroyd,Graham
Amount sold: 13,408 @ 284.00p
Value: £38,078.72